The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure by Yanagisawa, S et al.
RESEARCH ARTICLE
The dynamic shuttling of SIRT1 between
cytoplasm and nuclei in bronchial epithelial
cells by single and repeated cigarette smoke
exposure
Satoru Yanagisawa, Jonathan R. Baker, Chaitanya Vuppusetty, Takeshi Koga,
Thomas Colley, Peter Fenwick, Louise E. Donnelly, Peter J. Barnes, Kazuhiro Ito*




SIRT1 (silent information regulator 2 homolog 1) is a crucial cellular survival protein espe-
cially in oxidative stress environments, and has been thought to locate within the nuclei, but
also known to shuttle between cytoplasm and nuclei in some cell types. Here, we show for
the first time the dynamics of SIRT1 in the presence of single or concurrent cigarette smoke
extract (CSE) exposure in human bronchial epithelial cells (HBEC). In BEAS-2B HBEC or
primary HBEC, SIRT1 was localized predominantly in cytoplasm, and the CSE (3%) induced
nuclear translocation of SIRT1 from cytoplasm in the presence of L-buthionine sulfoximine
(an irreversible inhibitor of γ-glutamylcystein synthetase), mainly through the activation of
phosphatidylinositol 3-kinase (PI3K) α subunit. This SIRT1 nuclear shuttling was associated
with FOXO3a nuclear translocation and the strong induction of several anti-oxidant genes
including superoxide dismutase (SOD) 2 and 3; therefore seemed to be an adaptive
response. When BEAS-2B cells were pretreated with repeated exposure to a lower concen-
tration of CSE (0.3%), the CSE-induced SIRT1 shuttling and resultant SOD2/3 mRNA
induction were significantly impaired. Thus, this result offers a useful cell model to mimic the
impaired anti-oxidant capacity in cigarette smoking-associated lung disease such as chronic
obstructive pulmonary disease.
Introduction
Sirtuins are nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylase, which
are originally found as the human homologs of silent information regulator 2 (Sir2) genes in
Saccharomyces cerevisiae [1]. So far, seven isoforms of sirtuins have been identified in human
(SIRT1-SIRT7) [2]. Through their different intracellular distribution [3] and specificity toward
diverse acetylated substance proteins [4–6], sirtuins are known to regulate various cellular pro-
cesses such as apoptosis, cellular senescence, endocrine signaling, glucose homeostasis and
aging [7,8]; most of which are built on the delicate balances between oxidative vs anti-oxidative
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enzymes. Particularly, SIRT1 is known to deacetylate transcription factor Forkhead box O3
(FOXO3a), leading nuclear translocation of FOXO3a to stimulate transcription of anti-oxidant
genes such as superoxide dismutase (SOD) [9]. Among them, SIRT1 is the most extensively
studied sirtuin in mammals, and redox regulation of SIRT1 is now elucidated to be strongly
associated with resolution of inflammation and cellular senescence [10–12]. In addition, the
dysregulation of SIRT1 was reported in many aging associated diseases or diseases with ciga-
rette smoke (CS)-exposure [13,14]; both of which are characterized by the aberrant oxidant /
anti-oxidant regulations [15]. SIRT1 was originally found as a nuclear protein [16,17]; however
recent reports have shown that SIRT1 is not anchored exclusively in the nucleus [18–20] but
dynamically shuttles between the cytoplasm and nucleus [21–23]. Due to SIRT1 ability to dea-
cetylate and modify the functions of various different substrates, such dynamic shuttling
seems to be reasonable for SIRT1 to regulate cellular conditions efficiently. However, any
abnormalities in SIRT1 shuttling has not investigated. Therefore, the present study was
designed to clarify the dynamics of SIRT1 protein under oxidative stress and also examined
the impact of cigarette smoking on SIRT1 shuttling by comparing the effects of repeated CS
extract (CSE) pre-treatment with that of single CSE exposure, which might shed new light on
the novel molecular mechanisms of smoking associated diseases and also serve useful in vitro
model to mimic concurrent smoking exposure in vivo.
Materials and methods
Reagents
Commercially available reagents were obtained as follows: RPMI medium 1640 (RPMI 1640)
(#11875), polymerase chain reaction (PCR) primer for SIRT1 (Hs01009005) and GNB2L1
(Hs00272002) were from Life Technologies (Carlsbad, CA, USA); fetal bovine serum (FBS),
complete protease inhibitor cocktail (#11836153001), anti-SIRT6 antibody (#S4197), anti-
HDAC2 antibody (#H2663), thiazolyl blue tetrazolium bromide for MTT assay (M2003), L-
buthionine-sulfoximine (BSO) (#B2515), AS605240 (#A0233), rapamycin (#R8781), dimethyl
biguanide hydrochloride (metformin) (#D150959), NU7026 (N1537), Z-Leu-Leu-Leu-al (MG-
132) (#C2211), cycloheximide (CHX) (#C7698), resveratrol (#R5010) and sirtinol (#S7942)
were from Sigma-Aldrich Co. LLC (St Louis, MA, USA); anti-SIRT1 antibody (sc-15404),
PIK75 (#sc-296089), IC87114 (#sc-364509), anti-Nrf2 antibody (#sc-13032), anti-α-tubulin
antibody (#sc-5286), anti-Lamin A/C antibody (#sc-7292) and anti-chromosomal region
maintenance 1 (CRM1) antibody (#sc-5595) were from Santa Cruz Biotechnology (Santa Cruz
Biotechnology, CA, USA); anti-β-actin antibody (#ab6276) was from Abcam plc. (Cambridge,
UK); goat-derived peroxidase-conjugated anti-mouse (#P0447) or anti-rabbit (#P0448) sec-
ondary antibodies were from Dako (Cambridge shire, UK); anti-phospho-SIRT1 (Ser47) anti-
body (#2314), anti-phospho-Akt (Ser47) (p-Akt) antibody (#4060) and anti-total Akt antibody
(#4691) were from Cell Signaling Technology (Danvers, MA, USA); GSK2636771 (#S8002),
BIRB796 (#S1574) and U1026 (#S1102) were from Selleck biochemicals (Houston, TX, USA);
N-acetyl-Leu-Leu-Norleu-al (ALLN) (#208750) and Akt inhibitor (Akt Inhibitor II) were from
Millipore (U.K.) Limited (Hertfordshire, U.K.).
Cells
The BEAS-2B cell line (SV40-immortalized human airway bronchial epithelial cell line) were
purchased from the American Culture of Tissue Collection, and were grown in complete
growth medium (RPMI 1640 supplemented with heat-inactivated 10% FBS and 1% L-gluta-
mine) at 37 ˚C / 5% CO2. Before use, cells were starved for 24 hours in minimum medium
(RPMI 1640 supplemented with 1% FBS and 1% L-glutamine). In the BSO pretreatment
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model, cells were pre-incubated with BSO for 16–18 hours. Various inhibitors or activators
were added 30 min prior to the cigarette smoke extract (CSE) exposure. Primary cells were
obtained as follows: human airway epithelial cells of bronchial origin (hAEC) and air-liquid
interface (ALI) cultured human bronchial epithelial cells (HBEC) were from Epithelix-Sarl
(Geneva, Swiss); human pulmonary artery endothelial cells (hPAEC) were from Lonza (#CC-
2530, Slough, UK). For the analysis of clinical samples, human primary bronchial epithelial
cells were extracted from lung tissue from patients with chronic obstructive pulmonary disease
(COPD) undergoing lung resection surgery at the Royal Brompton Hospital. The characteris-
tics of patients with chronic obstructive pulmonary disease (COPD) were as follows (mean ±
SD); 3 male and 1 female, 68.75 ± 9.8 years old, pack year (number of cigarettes smoked per
day/20 x duration of smoking): 82.0 ± 58.7, FEV1 (forced expiratory volume in one second):
1.56 ± 3.1L (62.0 ± 18.2% predicted normal), FEV1/FVC (forced vital capacity): 49.0 ± 14.0%.
All subjects gave informed written consent and the study was approved by the NRES London-
Chelsea Research Ethics committee (study number 09/H0801/85). The cells were cultured as
monolayers in LHC-9 media (Invitrogen, Paisley, UK) on collagen (1% w/v) coated plates.
Preparation of CSE
One full-strength Marlboro cigarette with filter removed (Phillip Morris, London, UK) was
bubbled into 10 ml of minimum medium, at a rate of one cigarette per 1.5 minutes. CSE was
then passed through a 0.2μm filter to sterilize and remove particulate matter and was used
immediately. The optical density was measured at 320λ wavelength, and the solution was
diluted to be OD = 0.85 (this is original stock as 100%). The stock CSE was thereafter diluted
with culture media to appropriate percentages of CSE solution.
Protein extraction and Western blotting (WB)
Cytoplasmic fraction was prepared using modified radio-immuno-precipitation assay (RIPA)
buffer (50 mM Tris HCl pH 7.4, 0.5% NP-40, 0.5% w / v Na-deoxycholate, and 150 mM NaCl)
with freshly added complete protease inhibitor cocktail. This lysis buffer was confirmed to
extract cytoplasmic rich fraction based on β-actin and Lamin A/C staining in Western blotting.
This method has been used for the experiments shown in Figs 1 and 2, S1 and S2 Figs. In fol-
lowing experiments, cytoplasmic fraction and nuclear fraction were prepared using Nuclear
Extract Kit (#40010, Active Motif, La Hulpe, Belgium) according to the manufacture’s
instruction.
The cell extracts prepared above were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE), transferred to nitrocellulose membrane, and then incubated
overnight with anti-SIRT1 antibody (1:1,000 dilutions, #sc-15404), anti-SIRT6 antibody
(1:3,000 dilutions), anti-HDAC2 antibody (1:200,000 dilutions), anti-p-Akt antibody (1:500
dilution), anti-Total-Akt antibody (1:1,000 dilutions), anti-Nrf2 antibody (1:1000, dilutions)
or anti-CRM1 antibody (1:200 dilutions). To standardize the expression of each protein, the
membranes were re-probed with anti-β-actin antibody (1:200,000 dilutions) or anti-α-tubulin
antibody (1:2,000 dilutions), anti-Lamin A/C antibody (1:500 dilutions). The membranes were
then incubated with the appropriate peroxidase-conjugated secondary antibodies (1:3000 dilu-
tions each). The bound antibodies were visualized by chemiluminescence (ECL plus; GE
healthcare, Buckinghamshire, UK).
MTT assay
After the removal of supernatant, cells were washed with phosphate buffered saline (PBS)
once, and incubated with 1 mg / ml thiazolyl blue tetrazolium bromide solution for 1 hour at
SIRT1 nuclear shuttling by cigarette smoke
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37 ˚C / 5% CO2. Formazan crystals were dissolved in DMSO, and optical density was mea-
sured at 550 λ wavelength. Cell viabilities were represented as the relative ratio to that of non-
treatment group.
Protein half-life assay
After 16 hours pretreatment with or without 100 μM BSO, BEAS-2B cells were exposed with
or without 3% CSE from 1 to 24 hours in the presence of 30 min pre-incubation with cyclohex-
imide (CHX) (100 ng / ml). At different time points, cells were harvested and SIRT1 protein
levels were assayed by SDS-PAGE / WB.
Reverse transcriptase quantitative PCR (RT-qPCR)
Total cellular RNA was extracted using RNeasy mini kit (Qiagen, Valencia, CA, USA) and
cDNA was prepared by using Multiscribe reverse transcriptase (Applied Biosystems, Warring-
ton, UK). The RT-qPCR analysis of SIRT1 and GNB2L as a house keeping gene, were per-
formed using Taqman primers and probe set from Applied Biosystems in a Corbett Rotor-
Gene 3000 (Corbett Research Sortlake, NSW, Australia).
Analysis of nascent protein synthesis
Nascent protein synthesis was measured by modifying the protocol for Click-IT1 L-homopro-
pargylglycine (HPG) Alexa Fluor Protein Synthesis Assay kits (#C10429, ThermoFisher
Fig 1. Localization of SIRT1 in human bronchial epithelial cells. (A) SIRT1, SIRT6 and HDAC2 protein expressions are shown in
cytoplasmic and nuclei fraction. Lamin A/C and α-tubulin was used for loading control of nuclear and cytoplasmic fractions,
respectively. (B) SIRT1 localization in BEAS-2B cells was detected by immunocytochemistry. Upper panel showed SIRT1
immunoreactivity, and lower panel indicated negative control (× 40 in BD Pathway 435 bioimager). (C) SIRT1 subcellular localization
was examined for the different human primary cells, such as human airway epithelial cells of bronchial origin (hAEC, passage 2 and 4),
air-liquid interface cultured human bronchial epithelial cells (ALI) and human pulmonary artery endothelial cells (hPAEC).
https://doi.org/10.1371/journal.pone.0193921.g001
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Fig 2. PI3Kα is involved in the CSE-induced SIRT1 reduction in the presence of L-buthionine-sulfoximine (BSO) in cytoplasmic fraction. (A)
After pretreatment with 100 μM BSO for 16 hours, BEAS-2B cells were exposed to the 3% CSE for up to 24 hours. SIRT1 protein and phosphorylated
Akt/Akt ratio(p-Akt / Total-Akt) were assayed at different time point by SDS-PAGE / WB in cytoplasmic fraction. (B) SIRT1 protein levels were
examined at different concentration of CSE with or without 100 μM BSO pretreatment. All values were mean value ± SEM of at least three experiments.
 p< 0.01, compared with the values of non-treatment group; †† p< 0.01 between the absence or presence of BSO. (C) Various inhibitors against PI3K
signaling pathway molecules were added 30 min prior to the CSE exposure (0.1 μM of PIK75 for PI3Kα inhibitor, 10 μM of GSK2636771 for PI3Kβ
inhibitor, 10 μM of AS605240 for PI3Kγ inhibitor, 5 μM of IC87114 for PI3Kδ inhibitor, and 0.02 μM of rapamycin for mTOR inhibitor). The Akt
SIRT1 nuclear shuttling by cigarette smoke
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scientific, Rockford, IL, USA). In brief, cells were at first cultured with methionine free RPMI
medium (#14517–01, ThermoFisher scientific) for 30 min. Then medium was replaced with
CSE- or vehicle-containing methionine free RPMI supplemented with 50 μM Click-IT1 HPG,
which was incorporate into the newly synthesized proteins instead of methionine. After 6
hours, cells were harvested and lysed for WCEs preparation. The WCEs products were
immuno-precipitated by rabbit-derived anti-SIRT1 antibody (#sc-15404, Santa Cruz Biotech-
nology) with the Protein A magnetic beads (#10001D, Life Technologies), and additionally
labelled with Biotin-Azide (#B10184, ThermoFisher scientific) in the presence of cupper,
according to the manufacture’s instruction. After separation with SDS-PAGE / WB, biotin
labelled SIRT1 (biotin-SIRT1) was then detected by the HRP-conjugated streptavidin (1:1,000
dilutions, ThermoFisher scientific). To standardize the biotin-SIRT1, the membranes were re-
probed with mouse-derived anti-SIRT1 antibody (1:8,000 dilutions, #SAB1404972, Sigma-
Aldrich), and then incubated with the goat-derived anti-mouse peroxidase-conjugated second-
ary antibodies (1:3000 dilutions). Newly synthesized SIRT1 was expressed as relative intensity
calculated by the ratio of the mean band intensity for biotinylated SIRT1 to the mean band
intensity for the total SIRT1 protein.
SIRT1 motif change by oxidative stress
The various antibodies against different part of SIRT1 were used for examining the protein
motif changes caused by oxidative stress. We used anti-SIRT1 antibodies from; Santa-cruz
technology (#sc-15404 for① indicated in Panel F in S2 Fig. (F)), Sigma-Aldlich (#5322 for②,
#5447 for③, #SAB1404972 for④); Cell signaling technology (#9475 for⑤); and OriGene
(Rockville, MD, USA) (#TA303784 for⑥).
Immunofluorostaining for SIRT1 in BEAS-2B cells
Immunostaining of SIRT1 was done using Histostain-Plus1 IHC kit (#85–9043, Invitrogen,
Paisely, UK). Briefly, BEAS-2B cells were cultured on the chamber slide, and then fixed in
3% formaldehyde fixative solution for 15 min, and peameabilized by 0.1% triton X-100 in 10
mM PBS for 30 min. After blocking with serum blocking solution (#85–9043, Invitrogen), the
cells were incubated with FITC-conjugated anti-SIRT1 polyclonal antibody (1:100 dilution,
#orb103489, biorbyte, Cambridge, UK) overnight at 4 ˚C. The immunoreactions were then
embedded in the DAPI (4’,6-diamidino-2-phenylindole) containing mounting solution (Pro-
Long1 Diamond Antifade Mountant with DAPI, ThermoFisher scientific, Rockford, IL,
USA), as manufacture’s instruction. The slides were analyzed by BD Pathway 435 bioimager
system (with 40X Olympus Plan Fluorite objective, 0.75 numerical aperture, Lumenera-Infin-
ity 3–1 12 bit CCD camera) at room temperature using BD Atto Vision softeware (BD, New
Jersey, US).
Malondialdehyde (MDA) assay
MDA was quantified using OxiSelect™ TBARTS assay kit (#STA-330, Cambridge Bioscience,
Cambridge, UK). Briefly, the cytoplasm samples were thawed on ice and centrifuged for 1 or 2
min at 4˚C, 13000rpm, before use. Twenty μl of diluted samples (0.5μg/mL protein) or
activation status (p-Akt / Total-Akt) and SIRT1 protein levels were evaluated by SDS-PAGE / WB. (D, E) The concentration dependent effects of PIK75
on the SIRT1 and Akt phosphorylation levels were examined using CSE exposure with BSO pretreatment model. The ratio of p-AkT/Total-Akt or
SIRT1 levels were fitted with the sigmoid-curve, and calculated for the IC50 of PIK75 (E, respectively). All values were mean value ± SEM of at least
three experiments.  p< 0.01, compared with the values of non-treatment group; †† p< 0.01 between the two groups.
https://doi.org/10.1371/journal.pone.0193921.g002
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standards were mixed and incubated with equal volume of SDS lysis solution for 5min at room
temperature (RT) with shaking in PCR plates. TBA reagent was then added and mixed with
the samples and after 5–15 min at RT was set up for 1 hour at 100˚C in a PCR cycler. The plates
were then incubated for 15 min at 4˚C in a refrigerator. Fifty μl of this solution was then trans-
ferred to a half- area 96-well black plate and MDA was detected by fluorescence with 540λ
excitation and 590λ emission. The amount of MDA in the samples was calculated using the
standard curve.
Statistical analysis
The in vitro data using BEAS-2B cells were expressed as mean values ± SEM. Data were ana-
lyzed by one way ANOVA followed by Turkey’s or Sheffe’s F-test to adjust for multiple com-
parisons (Statcel 2, OMS publishing Inc., Saitama, Japan). An unpaired two-tailed Student’s t-
test was used for single comparisons. For the analysis of clinical samples, data were expressed
as mean values ± SD, and statistical significance was assessed by Mann-Whitney U test for sin-
gle comparisons, or by using non-parametric Shirley-Williams test. All reported P values are
two-sided, and P values of less than 0.05 were considered statistically significant.
Results
SIRT1 is localized in cytoplasm in human bronchial epithelial cells
SIRT1 has traditionally been reported to locate mainly within the nucleus, but some reports
elucidated that the SIRT1 potentially exists either in the nucleus or cytoplasm, as SIRT1 exerts
different function with diverse substrate at each subcellular component. As shown in Fig 1A,
SIRT1 is localized in cytoplasm of BEAS-2B cell line at normal culture condition, which was
obviously contrast to the other de-acetylating enzymes SIRT6 and HDAC2; both of which
located exclusively in the nucleus (Fig 1A). Immunocytochemistry experiment also confirmed
abundant SIRT1 located mainly within the cytoplasm (Fig 1B). As BEAS-2B cell line is an
immortalized bronchial epithelial cell line, we also investigated the localization of SIRT1 in
human primary airway epithelial cells of bronchial origin (hAEC: passage 2 and 4) in mono-
layer culture and air-liquid interface (ALI)-cultured human bronchial epithelial cell (HBEC).
In both type of bronchial cells, SIRT1 was located mainly within cytoplasm (Fig 1C). On the
other hand, SIRT1 was found within the nucleus in human pulmonary artery endothelial cells
(hPAEC), suggesting that the distribution of SIRT1 differed from one cell type to another as
previously reported [22,24].
Cigarette smoke extracts decreased cytoplasmic SIRT1
As shown in Panel A and B in S1 Fig, CSE exposure caused a reduction in SIRT1 protein
expression in cytoplasmic fractions in a concentration and time-dependent manner. SIRT1
protein expression was significantly decreased at 20% CSE although the cell viability was sig-
nificantly reduced at higher than 10% CSE (61 ± 12% reduction).
Therefore, cells were treated with L-buthionine sulfoximine (BSO: an irreversible inhibitor
of γ-glutamylcystein synthetase [25]), which depletes intracellular glutathione storage, making
cells more susceptible to the exogenous oxidative stress [25] without increasing cell toxicity. In
fact, it has been reported that available glutathione storage is decreased in the chronic smokers
[26,27]. As shown in Fig 2A and 2B, in the presence of BSO, cytoplasmic SIRT1 was decreased
by lower concentrations of CSE (3%) after 24 hours exposure. No significant reduction of cell
viability was seen.
SIRT1 nuclear shuttling by cigarette smoke
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At same time, the 3% CSE exposure with the pretreatment of 100 μM BSO (3% CSE/BSO)
significantly increased the phosphorylation of Akt (Fig 2A), suggesting the phosphatidylinosi-
tol 3-kinase (PI3K) signaling pathway was activated in this condition. To identify the isoform
of PI3K involved in SIRT1 reduction, we tested various inhibitors of PI3K pathway (0.1 μM of
PIK75 for PI3Kα inhibitor, 10 μM of GSK2636771 for PI3Kβ inhibitor, 10 μM of AS605240 for
PI3Kγ inhibitor, 5 μM of IC87114 for PI3Kδ inhibitor, and 0.02 μM of rapamycin for mTOR
inhibitor). As shown in Fig 2C, only PIK75 among all inhibitors tested suppressed the CSE-
induced Akt phosphorylation effectively (Fig 2C, upper panel), and significantly reversed the
reduction of SIRT1 protein under oxidative stress (Fig 2C, lower panel). PIK75 concentration-
dependently reversed SIRT1 suppression (Fig 2D and 2E) with an IC50 value of 14.3 nM and
suppressed p-Akt/Total-Akt ratio (Fig 2E and 2F) with an IC50 value of 9.1 nM, respectively;
these values were very close to the previously reported IC50 of PIK75 for PI3Kα enzyme activ-
ity (IC50: 5.8 nM) [28]. Therefore, these results suggested that PI3K, especially α subunit, plays
an important role in regulating SIRT1 suppression under oxidative stress. Furthermore, we
also examined the effect of NU7026 (DNA dependent protein kinase (DNA-PK) inhibitor,
3.3 μM) as PIK75 is also known to inhibit DNA-PK [28], and also tested other signaling inhibi-
tors such as 1,1-dimethyl-biguanide hydrochloride (5’ AMP-activated protein kinase (AMPK)
activator, 5 mM), BIRB796 (p38 mitogen activated protein kinase (MAPK) inhibitor, 1 μM)
and U1026 (MAPK / extracellular-signal-regulated kinases (ERK) kinase (MEK) 1 / 2 inhibi-
tor, 1 μM), however none of which had any effects on SIRT1 suppression.
To clarify the mechanism of reduction of cytoplasmic SIRT1, we investigated role of protea-
some degradation using proteasome inhibitors, Z-Leu-Leu-Leu-al (MG-132: 8 μM) or N-Acet-
hyl-Leu-Leu-Norleu-al (ALLN: 10 μM) (Panel A in S2 Fig), SIRT1 protein half-life in the
presence of cycloheximide (Panel B in S2 Fig) and the translational regulation of SIRT1 protein
using Click-IT1 assay (Panel C in S2 Fig), but none of systems were responsible for the reduc-
tion of cytoplasmic SIRT1. We also investigated the level of SIRT1 gene transcription deter-
mined by SIRT1 mRNA levels by reverse transcriptase quantitative polymerase chain reaction
(RT-qPCR). Although the 24 hours exposure with CSE decreased the SIRT1 mRNA only in
the presence of BSO (Panel D in S2 Fig), the reduction was not reversed by PIK75 (Panel E in
S2 Fig). Additionally, we had concerns on the modification of the antibody recognition motif
of SIRT1 by oxidative stress, resulting in failure of SIRT1 detection by the antibody used rather
than actual reduction of SIRT1 protein. Therefore, we tested various antibodies that recognize
epitopes within different regions of the SIRT1 protein, however, all antibodies confirmed the
reduction of SIRT1 protein levels by CSE exposure with BSO pretreatment (Panel F in S2 Fig),
therefore antibody detection motif on SIRT1 was not modified by oxidative stress. Finally, to
investigate the possibility of secretion of SIRT1 as the mechanism of cellular SIRT1 reduction,
we also detected SIRT1 in the cell culture supernatant, but no significant increase in SIRT1
protein after CSE exposure was observed (Panel G in S2 Fig).
Cigarette smoke extracts induced shuttling of SIRT1 from cytoplasmic to
nuclei
As shown above, none of the mechanisms such as transcriptional, translational, or post-trans-
lational regulations, seemed to be associated with SIRT1 reduction in cytoplasmic fraction
under oxidative stress. Therefore, we next investigated the localization of SIRT1 under oxida-
tive stress. Interestingly, cytoplasmic SIRT1 dramatically translocated to nucleus after 24 hour
exposure of CSE in the presence of BSO in BEAS-2B cells (Fig 3A and 3B, S3 Fig, Panel A in S4
Fig). This dynamic shuttling between cytoplasm and nucleus seemed to be SIRT1 specific phe-
nomenon, because both SIRT6 and HDAC2 stayed within the nucleus irrespective of the CSE
SIRT1 nuclear shuttling by cigarette smoke
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Fig 3. CSE-induced SIRT1 reduction is actually due to shuttling of cytoplasmic SIRT1 to nuclei. BEAS-2B cells were pretreated
with or without 100 μM BSO in the presence or absence of 3% CSE. After 24 hours, localization of SIRT1, SIRT6, HDAC2 and
CRM1 in cytoplasm (A) and nuclei (B) were examined by SDS-PAGE / WB. (C) SIRT1 localization after CSE exposure for 24 hours
in the presence of BSO in BEAS-2B cells were detected by immunocytochemistry (× 40 in BD Pathway 435 bioimager). (D-G) In the
3% CSE exposure with 100 μM BSO pretreatment model, the SIRT1 shuttling was examined in the human primary bronchial
epithelial cells (D, E) or air-liquid interface cultured human bronchial epithelial cells (F, G). (H, I) After CSE exposure with BSO
pretreatment in BEAS2B, the effect of PIK75 (0.1 μM) on the SIRT1 shuttling was examined. (J) SIRT1 in nuclear fraction after
nicotine (10 μM) or anisomycin (10 μg / ml) treatment for 6 hours in BEAS-2B. (K) Effects of Akt inhibitor (10 μM) on SIRT1
SIRT1 nuclear shuttling by cigarette smoke
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stimulation with BSO pretreatment; in case of SIRT6 or HDAC2, only nuclear protein frac-
tions had a tendency of reduction under oxidative stress without changes in its location.
Immunocytochemistry also showed nuclear localization after CSE treatment (Fig 3C) com-
pared to the baseline in Fig 1B. Most importantly, the shuttling of SIRT1 to nuclei by CSE was
also confirmed in primary cells, such as hAEC or ALI-cultured HBEC (Fig 3D and 3E or 3F
and 3G, respectively). The shuttling of SIRT1 seemed to be caused by the active transport
because its dynamics was in parallel to that of chromosome maintenance region 1 (CRM1)
protein (Fig 3A and 3B), which is known to recognize nuclear export sequence and function as
a cargo for SIRT1 nuclear export [22]. Furthermore, the nuclear translocation of SIRT1 under
oxidative stress in BEAS-2B cells was almost completely reversed by PIK75, the PI3Kα specific
inhibitor (Fig 3H and 3I). Thus, the SIRT1 located mainly in cytoplasm in bronchial epithelial
cells at normal condition, and translocated from cytoplasm to nucleus under oxidative stress,
which was mediated mainly through PI3Kα signaling. The SIRT1 shuttling was not induced
by nicotine, an Akt activator [29] as shown in Fig 3J; in addition, Akt inhibitor did not inhibit
3% CSE-induced SIRT1 nuclear translocation, either (Fig 3K). This suggests that the transloca-
tion of SIRT1 is regulated downstream of PI3Kα before Akt comes into play. The SIRT1 shut-
tling was not induced by anisomycin, a JNK activator at 6 hours or 24 hours after treatment
(Fig 3J). SP-600125, a JNK inhibitor, did not inhibit CSE-induced SIRT1 shuttling, either
(right panel in Fig 3L). Although Nasrin and colleagues reported that JNK is involved in
SIRT1 shuttling to the nuclei in hydrogen peroxide stimulated human embryonic kidney
(293T) cells [30], it was not the case in our current study with cigarette smoke conditioned
media. At least, N-acetyl cysteine clearly inhibited CSE-induced SIRT1 shuttling, suggesting
oxidative stress to drive the shuttling process (left panel in Fig 3L).
The shuttling of cytoplasmic SIRT1 to the nucleus seemed to be cell-protective, because
nuclear SIRT1 is strongly associated with the mRNA induction of some anti-oxidative pro-
teins; not only with the well-known SIRT1 downstream target superoxide dismutase 2 (SOD2)
[31], but also with the hemoxygenase-1 (HO-1) (Fig 4A), SOD3 (Fig 4B) and NADPH quinone
oxidoreductase-1 (NQO-1). Such beneficial effect (mRNA induction of anti-oxidative pro-
teins) was also confirmed to be inhibited by the PI3Kα inhibitor, PIK75 (Fig 4A). As well as in
mRNA levels, HO-1 and SOD2 proteins were also induced by CSE and inhibited by PIK-75
(Fig 4B). Furthermore, although FOXO3a is known to be an important transcription factor to
induce these anti-oxidant gene expression and also the function is regulated by SIRT1 [32], we
found 3% CSE also increased FOXO3a in nuclei together with SIRT1 (Fig 4C). Taken together,
SIRT1 translocation from cytoplasm to nucleus is a normal protective mechanism against “sin-
gle” oxidative stress, by induction of potent anti-oxidant enzymes.
Repeated low concentrations cigarette smoke exposure impaired the SIRT1
shuttling to nuclei
SIRT1 nuclear shuttling seems to be important adaptive response against oxidative stress.
However, the protective mechanism (such as anti-oxidant capacity) is known to be impaired
in some diseases, especially chronic obstructive pulmonary disease (COPD). As the chronic
exposure of cigarette smoke or indoor smoke is the major risk factor for the pathogenesis
of COPD, we set up a cell model primed by the repeated cigarette smoke exposure. As shown
in Fig 5A and 5B (and Panel B in S4 Fig), pre-treatment of BEAS-2B cells with a lower
protein in nuclei from cells stimulated with 3% CSE for 24 hours. (L) Effects of N-acetyl cysteine (NAC, 10 mM) and SP-600125 (SP,
10 μM) on SIRT1 protein in nuclei from cells stimulated with 3% CSE for 24 hours. All values were mean value ± SEM of at least
three experiments.  p< 0.05,  p< 0.01, compared with the values of non-treatment group; †† p< 0.01 between the two groups.
https://doi.org/10.1371/journal.pone.0193921.g003
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concentration of CSE (0.3%, every 24 hours, x3) in combination with MG-132 (0.1 μM, every
24 hours, x3, to avoid any effects of proteasome degradation of SIRT1 or other proteins)
almost completely inhibited SIRT1 nuclear translocation by CSE (3%) exposure in the pres-
ence of BSO (100 μM). This suggested that the repeated exposure of low concentrations of CSE
impaired the protective mechanism against oxidative stress by inhibition of SIRT1 shuttling.
As this impairment of SIRT1 shuttling was not observed by repeated CSE without MG-132
(Fig 5A), degradation of SIRT1 or any other proteins will affect the outcome seen in Fig 5B. In
addition, we determined cellular oxidative level as malondialdehyde (MDA). As shown in
Fig 4. CSE-induced SIRT1 nuclear translocation was associated with increases in anti-oxidant gene and protein expression. (A)
The messenger RNA levels of superoxide dismutase 2 (SOD2), SOD3, NADPH quinone oxidoreductase-1 (NQO-1) and
hemoxygenase-1 (HO-1), all of which were normalized to mRNA expression of a GNB2L1 housekeeping gene, were assessed by the
reverse transcription-quantitative polymerase chain reaction (RT-qPCR) 24 hours after 3% CSE exposure with BSO. All values were
mean values ± SEM of at least three experiments.  p< 0.05,  p< 0.01, compared with the values of non-treatment group;
†† p< 0.01, compared between the two groups. (B) The protein levels of HO-1, NQO-1 and SOD2 were assessed by SDS-PAGE/WB.
(C) SIRT1 and FOXO3a protein in cytoplasmic fraction (top) and nuclear fraction (bottom) 24 hours after 3% CSE exposure with
BSO. PIK75 (0.1 μM) was also treated before CSE exposure. The band density of SIRT1 and FOXO3a were also calculated and
corrected to that of Lamin A/C.  p< 0.05,  p< 0.01, compared with the values of BSO only group; † p< 0.05, compared between
with or without PIK75.
https://doi.org/10.1371/journal.pone.0193921.g004
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Fig 5C, single treatment of 3% CSE increased oxidative stress at 6 hours after stimulation, but
disappeared at 24 hours, although this was reversed by PI3Kα inhibitor PIK75, suggesting
induction of anti-oxidants are involved in reduced oxidative stress at 24hours. In contrast,
when cells were primed with repeated low concentration CSE, the level of oxidative stress was
still high at 24 hours after CSE stimulation. Thus, impairment of SIRT1 nuclear shuttling
causes exposure of higher level of oxidative stress continuously due to no induction of anti-
oxidants.
Fig 5. Shuttling of SIRT1 to nuclei was impaired by repeated CSE priming and in COPD. (A) In CSE exposure with BSO pretreatment model, the
effects of different concentration of recurrent CSE in the presence or absence of repeated 0.1 μM MG-132 were examined. (B) The effect of 0.3%
CSE in the presence of 0.1 μM MG-132 on SIRT1 shuttling under the oxidative stress was confirmed. (C) Cellular oxidative stress determined as
malondialdehyde in 3% CSE stimulated and in repeated CSE priming with 3% CSE stimulated cells. (D) SIRT1 proteins in nuclei [N] and cytoplasm [C]
in CSE exposed primary bronchial epithelial cells from subjects with or without COPD. (E) Nuclear to cytoplasmic (N/C) ratio of SIRT1 in experiments
(D). The data were shown as the relative ratio of that of non-treatment group.  p< 0.05,  p< 0.01, compared with the value of non-treatment group;
† p< 0.05, †† p< 0.01, compared between the two group.
https://doi.org/10.1371/journal.pone.0193921.g005
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We also examined the SIRT1 shuttling of primary bronchial epithelial cells obtained from
the healthy subjects (n = 4) or COPD patients (n = 4). In normal subjects, the nuclear to cyto-
plasmic (N/C) ratio of SIRT1 were CSE dose-dependently increased, however SIRT1 nuclear
shuttling seemed to be impaired in those from COPD subjects (Fig 5D and 5E), which were
significant compared with the healthy subjects at higher than 10% CSE (Fig 5D and 5E). These
results suggested the impaired SIRT1 shuttling in the patients with COPD, which were com-
patible with our recurrent CSE exposure priming models in vitro.
Although, the molecular mechanism of impaired SIRT1 shuttling is not clear, the pretreat-
ment with a SIRT1 inhibitor (sirtinol, 10 μg/ml) almost totally blocked the CSE-induced
SIRT1 nuclear localization under the oxidative stress (Fig 6A), with resultant inhibition of
SOD2 and SOD3 mRNA induction (Fig 6B) although SIRT1 activator, resveratrol did not
affect SIRT1 nuclear translocation (S5 Fig). Interestingly, CRM1 is degraded by repeated ciga-
rette smoke, which was restored by the MG-132 treatment, resulting to enable the export of
SIRT1 into cytoplasm (S6 Fig). We also evaluate the effects of PI3K inhibitors, p38MAPK
inhibitors or ERK inhibitors as well as an mTOR inhibitor, but none of these inhibitors
Fig 6. Shuttling of SIRT1 to nuclei was impaired by SIRT1 inhibitor. (A) In the 3% CSE exposure with 100 μM BSO pretreatment model, the effect of
the SIRT1 inhibitor sirtinol (10 μg/ml) on SIRT1 shuttling and on the mRNA levels of SOD2 (B, left) and SOD3 (B, right) were examined. All values are
mean values ± SEM of at least three experiments.  p< 0.05,  p< 0.01, compared with the values of non-treatment group; † p< 0.05, †† p< 0.01,
compared between two groups. (C) The various kinase inhibitors were added 30 min prior to the final 3% CSE exposure (0.1 μM of PIK75 [P] for
PI3Kα, 10 μM of GSK2636771 [G] for PI3Kβ, 10 μM of AS605240 [A] for PI3Kγ, 5 μM of IC87114 [I] for PI3Kδ, 0.02 μM of rapamycin [R] for mTOR,
0.1μM of BIRB786 [B] for p38MAPK and 0.1μM of U0126 [U] for ERK signaling. SIRT1 and FOXO3a protein levels in nuclei were evaluated by
SDS-PAGE / WB.
https://doi.org/10.1371/journal.pone.0193921.g006
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reversed the impaired SIRT1 nuclear translation by repeated CSE exposure (Fig 6C). Thus,
recurrent smoking priming seemed to inactivate SIRT1, preventing SIRT1 from to translocat-
ing to nucleus, although the underlying molecular mechanisms are still unclear.
Discussion
In the current study, we have shown for the first time that the SIRT1 locates mainly in the cyto-
plasm in both immortalized and human primary bronchial epithelial cells under normal con-
dition. Our data suggest that a “single” oxidative stress event dynamically translocates SIRT1
to the nucleus where SIRT1 could exert its anti-oxidative properties, such as SOD2 and SOD3
mRNA induction, leading to reduction of cellular oxidative stress. However, repeated CSE
pre-exposure attenuated the SIRT1 shuttling and caused prolonged exposure of oxidative
stress, suggesting that the impaired SIRT1 shuttling might be a key molecular mechanism con-
tributing to the development of cigarette smoke (CS)-associated diseases such as chronic
obstructive pulmonary disease (COPD) and lung cancer.
In chronic smokers, the level of available glutathione in the whole body is decreased
[26,27], which is even more evident in sputum [33] and skeletal muscle [34]. To mimic this,
cells were treated with BSO, which is known to deplete intracellular glutathione storage, mak-
ing cells more susceptible to the exogenous oxidative stress [25]. In fact, BSO pretreatment
augmented CSE-induced SIRT1 reduction; in that condition, as low as 3% CSE could effec-
tively suppress the SIRT1. Importantly, the cell toxicity in this condition was milder than that
in high CSE exposure without BSO; these results suggested that CSE exposure with BSO pre-
treatment might be more appropriate model for analyzing chronic effect of cigarette smoking.
According to our data, the activation of PI3K seem to be associated with the SIRT1 reduc-
tion under the oxidative stress, and we identified the PI3Kα isoform among 4 isoforms
(p110α, p110β, p110γ and p110δ) [35] to be involved in SIRT1 shuttling in bronchial epithelial
cells by pharmacological evaluation. PIK75, a potent PI3Kα inhibitor, is also known to inhibit
DNA-PK. As shown in Fig 2D and 2E, an IC50 value of PIK75 on CSE-induced Akt phosphor-
ylation was similar to the IC50 for PI3Kα enzyme inhibition as previously published [28], and
also another DNA-PK inhibitor (NU7026) did not affect SIRT1 level. Therefore, the PI3Kα
isoform is dominantly involved in SIRT1 reduction by CSE exposure. Previously, we had
reported that PI3K signaling, especially the δ isoform is activated and up-regulated in the pres-
ence of oxidative stress, with this being associated with corticosteroid refractory inflammation
especially in monocytic cells, macrophages or peripheral blood mononuclear cells (PBMCs)
[36–39]. In the present study, no effect was seen of PI3Kδ inhibitor (IC87114) on the SIRT1
reduction under oxidative stress. This might be explained by the fact that the p110α is the
most abundant isoform in normal bronchial epithelial cells and PI3Kδ isoform is expressed
primarily in immune cells [40,41]. Interestingly, nicotine, an Akt activator, did not induce
SIRT1 shuttling and Akt inhibitor did not inhibit SIRT1 shuttling stimulated by 3% CSE.
Thus, SIRT1 nuclear translocation is regulated downstream of PI3Kα before Akt comes into
play. PI3Kα is known to phosphorylate other proteins directly [42], and it might happen inde-
pendently from Akt signaling. In addition, hydrogen peroxide is also reported to induce
SIRT1 nuclear translocation in human kidney cells via JNK1 activation [30]. However, Aniso-
mysine, JNK activator, did not induce SIRT1 shuttling, and also JNK inhibitor did not inhib-
ited CSE-induced SIRT1 shuttling. Therefore, in human bronchial epithelial cells or cigarette
smoke stimulation, JNK1 is unlikely involved in SIRT1 shuttling.
Although we found SIRT1 shuttling from cytoplasmic to nuclei by CSE stimulation, these
findings were different from the previous report by Caito et al [43]; in which, the oxidative
stress is reported to accelerate the nuclear to cytoplasmic export of SIRT1, leading to SIRT1
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degradation promptly through the proteasomal pathway in BEAS-2B cells. However in this
manuscript, SIRT1 was detected using immunofluorescent assay (IFA), which is sometimes
unreliable method because of the incomplete epitope specificity that each antibody recognize,
therefore it is not clear whether the antibody detected a full length protein, truncated protein
or just fragments. Such controversy about the results of IFA were appropriately discussed in
the report by Byles et al [24]; in that report, they finally concluded that intracellular SIRT1
location should be confirmed by the Western blotting (WB) combined with subcellular frac-
tionation. We confirmed the SIRT1 location through the various methods such as 1) the WB
combined with the subcellular fractionation, 2) the use of several anti-SIRT1 antibodies recog-
nizing different SIRT1 epitopes, and 3) the use of immunofluorescent assay. We think our
results to be more reliable and concluded that the SIRT1 locates predominantly in the cyto-
plasm under normal conditions.
The dynamic shuttling properties under oxidative stress seemed exclusively specific to
SIRT1 compared with other de-acetylating enzymes such as HDAC2 or SIRT6. The reasons
why SIRT1 shuttles between cytoplasm and nuclei in the presence of oxidative stress remains
unclear. However, some reports suggested that cytoplasmic SIRT1 functions as a reserve, in
case of an emergency [31]; it is therefore believed that under the condition such as oxidative
stress exposure, cytoplasmic SIRT1 translocates to the nucleus, exerting its cellular anti-oxida-
tive properties. In the presence of oxidative stress, SIRT1 is known to deacetylate FOXO3a
[32], which then induce anti-oxidative proteins such as SOD2, SOD3, NQO-1 and HO-1
[32,44,45]. In fact, we confirmed FOXO3a nuclear translocation in CSE stimulated cells in the
presence of BSO. Thus, the response of “single” CSE exposure is for adaptation and not appro-
priate in vitro model of CS-associated disease due to lack of chronic exposure of cigarette
smoke.
Therefore, we next examined if the repeated CSE pre-exposure (rCSE) affected SIRT1 shut-
tling. For that objective, we co-stimulated BEAS-2B cells not only with lower concentration of
CSE but also with low concentration of MG-132 (0.1 μM), so as to inhibit the proteasome deg-
radation of SIRT1 and other proteins, which is reported in the cigarette smoke-associated dis-
eases [46]. Although the repeated lower dose CSE (0.3%) pre-exposure itself did not have any
effects on SIRT1 shuttling, the repeated 0.3% CSE exposure in the presence of MG-132
(0.1 μM) clearly impaired SIRT1 shuttling. Considering that MG-132 prevents the CRM1 deg-
radation under CSE exposure, preserved CRM1 might contribute to the accelerated extra-
nuclear export of SIRT1; this might be the one reason why MG-132 is necessary for the
impaired SIRT1 shuttling on repeated CSE model. These rCSE priming seems to be the rea-
sonable in vitro model for analyzing the impaired SIRT1 dynamics in vivo, because the primary
bronchial epithelial cells from COPD subjects also showed similar dysregulation of SIRT1
shuttling.
The molecular mechanism behind impaired SIRT1 shuttling to nucleus by repeated pre-
exposure of low dose CSE was still unclear. To understand this, we used multiplekinase inhibi-
tors targeting PI3K, p38MAPK, ERK and mTOR, but all failed to reverse the impaired SIRT1
shuttling. We next investigated post-translational modifications of SIRT1, such as oxidation,
phosphorylation, ubiquitination and acetylation, but we did not find any changes in the post-
translational modifications of SIRT1 at the condition tested. However data did suggest that the
sirtuin inhibitor, sirtinol, completely inhibited SIRT1 nuclear shuttling and resultant SOD2
and SOD3 induction under oxidative stress, mimicking repeated CSE exposure. Previous
report [22] elucidated through a mutant study that; 1) SIRT1 has two nuclear export signals
(NES1 and NES2), and 2) strong nuclear export activity is mainly attributed to the NES2,
which locates inside the SIRT1 catalytic motif. Therefore, it might be possible that sirtinol not
only binds to the catalytic domain to inhibit its enzyme activity but also modified the activity
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of NES2, which then impair the SIRT1 shuttling. Further studies are required to identify the
molecular mechanism.
Our present study had some limitations. At first, SIRT1 shuttling would not be the only
mechanisms for SIRT1 reduction under oxidative stress, despite its importance in CSE expo-
sure (for up to 24 hours). Considering that the SIRT1 mRNA began to decrease at 24 hours,
other mechanisms would also contribute to SIRT1 protein reduction at later phase; for exam-
ple, SIRT1 mRNA instability by micro (mi)RNA would be the possible mechanism to be
explored [47] as well as proteasome/autophagy systems. Secondary, although we considered
SIRT1 shuttling to be cell-protective, these oxidant-resistant properties might contribute not
only to cell survival but also to the malignant transformation of the cell, with resultant lung
cancers as an important other CS-associated disease other than COPD. Such double-edged
sword effects of SIRT1 shuttling might positively or negatively influence the patients’ progno-
sis [48]. Therefore, the balancing mechanisms between the cell protective/anti-oxidative prop-
erties and the resultant risk for malignant transformation might also be explored in the future
study. We also performed preliminary staining of lung tissue on histological slides and could
not detect any SIRT1 within the nucleus. To compare the level of SIRT1 shuttling in non-
COPD and COPD, we would have to get fresh lung samples, and stimulate with CSE, or obtain
fresh lung biopsies after CSE challenge in humans in vivo. Thus, further clinical study will be
required.
In conclusion, cytoplasmic SIRT1 in bronchial epithelial cells seems to function as a reserve,
and after oxidative stress exposure it translocates to the nucleus to exert its cellular anti-oxida-
tive properties. We also have shown that impaired nuclear shuttling of SIRT1 might be associ-
ated with chronic CS exposure related diseases. Thus this impaired SIRT1 shuttling might be a
possible therapeutic target for treating CS-associated diseases, and our findings also stress the
need for smoking free environment.
Supporting information
S1 Fig. Cigarette smoke extract (CSE)-induced SIRT1 reduction. (A) BEAS-2B cells were
incubated with various concentration of CSE for 24 hours, and SIRT1 protein levels in whole
cell extract (WCE) were assayed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) / Western blotting (WB). (B) Time-dependency of SIRT1 reduction in the pres-
ence of 20% CSE was examined at different time point up to 24 hours.  p< 0.01, compared
with the values of non-treatment group.
(TIF)
S2 Fig. CSE-induced SIRT1 reduction was not due to proteasome degradation, reduction
of transcription or translational dysregulation. (A) BEAS2B cells were treated with or with-
out 3% CSE / 100 μM BSO, in the presence or absence of proteasome inhibitors such as Z-Leu-
Leu-Leu-al (MG-132: 8 μM) or ALLN (N-acetyl-Leu-Leu-Norleu-al: 10 μM). After 24 hours
exposure with CSE, SIRT1 protein levels were analysed. The Nrf2 was used as the control pro-
tein affected by proteasome inhibitors. (B) In the presence or absence of 3% CSE / 100 μM
BSO, protein half-life were examined using cyclohexamide (CHX: 100 ng / ml) pretreatment.
Then, the levels of SIRT1 were plotted at each time point, and protein half-life was investigated
for each condition. (C) The translational regulation of SIRT1 was assayed using Click-IT1
labelling method. Newly synthesized SIRT1 were tagged with biotin, which were then immu-
noprecipitated and detected by SDS-PAGE/WB. The biotin-SIRT/Total-SIRT were used for
assessing the nascent protein synthesis under the condition with or without BSO in the pres-
ence or absence of 3% CSE. (D) Samples were also collected 24 hours after CSE stimulaton,
and SIRT1 mRNA level was examined by RT-qPCR. (E) Time-dependent changes of SIRT1
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mRNA levels were also analyzed in the presence of PIK75 (0.1 μM). (F) Compare the ability of
various antibodies that recognize different motif of SIRT1 to detect SIRT1 protein modified by
oxidative stress. (G) SIRT1 secretion in the cell culture supernatants were assayed. All values
are mean values ± SEM of at least three experiments.  p< 0.05,  p< 0.01, compared with
the values of non-treatment group; †† p< 0.01, compared with or without 0.1 μM PIK75;
NLS = nuclear localization sequence; NES = nuclear export sequence.
(TIF)
S3 Fig. Full image of Western blotting of SIRT1 and housekeeping genes shown in Fig 3A
and 3B. (A) Cytoplasmic fraction was analyzed for SIRT1 (upper) and β-actin (lower). (B)
Nuclear fraction was analyzed for SIRT1 (upper) and Lamin A/C (lower).
(TIF)
S4 Fig. Time-dependency of Cigarette smoke extract (CSE)-induced expression of SIRT1
in nuclear fraction in the presence of BSO with/without priming with repeated 0.3% CSE.
BEAS2B cells were treated with or without 3% CSE / 100 μM BSO for 4, 8, 16 and 24 hours or
treated with 0.3% CSE in the presence of MG123 for 3 days and then stimulated with 3% CSE
in the presence of 100 μM BSO for 4, 8, 16 and 24 hours. SIRT1 protein levels in cytoplasm
(A) and nuclei (B) were assayed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) / Western blotting (WB). (C) Malondialdehyde (MDA) was measured in cyto-
plasm fraction (n = 3).
(TIF)
S5 Fig. Effects of resveratrol on CSE-induced SIRT1 nuclear translocation. (A) BEAS2B
cells were treated with Resveratrol (10μM) in the presence of BSO and stimulated with 3%CSE.
(TIF)
S6 Fig. Effects of MG132 on SIRT1, FOXO3a, CRM1 and Lamin A/C protein expression in
nuclei after repeated 0.3% CSE exposure. MG-132 was treated before every CSE treatment.
(TIF)
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